Federal contract award
75N93023F00002
CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93018D00009 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $443.3K |
| Current contract value | $443.3K |
| Potential contract value / ceiling | $443.3K |
| Start date | Sep 26, 2023 |
| Current end date | Mar 31, 2026 |
| Potential end date | Mar 31, 2026 |
| Latest award activity | Dec 19, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 19, 2025 | P00003 | $0 | CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT |
| Mar 28, 2025 | P00002 | $0 | CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT |
| Sep 25, 2024 | P00001 | $0 | CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT |
| Sep 26, 2023 | 0 | $443.3K | CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.